Steadview pares API maker stake in third exit in a month

Premium

In its third exit from an Indian portfolio company within a month, Asia focused hedge fund Steadview Capital has sold more stake in a publicly listed active pharmaceutical ingredients (API) maker. Steadview Capital Mauritius Ltd has pared nearly half of its stake in Hyderabad-based bulk drugs maker Neuland Laboratories Ltd to ......